{"id":38214,"date":"2013-08-29T09:41:15","date_gmt":"2013-08-29T13:41:15","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?post_type=news&#038;p=38214"},"modified":"2013-08-29T09:41:15","modified_gmt":"2013-08-29T13:41:15","slug":"statins-reduce-cardiovascular-events-in-elders-without-established-cvd","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2013\/08\/29\/statins-reduce-cardiovascular-events-in-elders-without-established-cvd\/","title":{"rendered":"Statins Reduce Cardiovascular Events in Elders Without Established CVD"},"content":{"rendered":"<p>Statins are associated with lower risks for myocardial infarction and stroke among elders without established cardiovascular disease, according to <a href=\"http:\/\/content.onlinejacc.org\/article.aspx?articleid=1732396\">a meta-analysis in the <em>Journal of the American College of Cardiology<\/em><\/a>.<\/p>\n<p>The analysis included eight randomized, placebo-controlled trials comprising nearly 25,000 patients aged 65 and older without CVD at baseline. During 3.5 years&#8217; follow-up, statin use was associated with a 39% reduction in the risk for MI and a 24% reduction in the risk for stroke. The researchers estimate that 24 patients would need to be treated for 1 year to prevent one MI, and 42 to prevent one stroke.<\/p>\n<p>There was a trend toward a reduction in mortality, but this did not reach statistical significance.<\/p>\n<p>The researchers say their study &#8220;provides first time evidence&#8221; that statins&#8217; cardiovascular benefits extend to people aged 65 and older without CVD.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Statins are associated with lower risks for myocardial infarction and stroke among elders without established cardiovascular disease, according to a meta-analysis in the Journal of the American College of Cardiology. The analysis included eight randomized, placebo-controlled trials comprising nearly 25,000 patients aged 65 and older without CVD at baseline. During 3.5 years&#8217; follow-up, statin use [&hellip;]<\/p>\n","protected":false},"author":577,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[495,7],"tags":[1910,818,584],"class_list":["post-38214","post","type-post","status-publish","format-standard","hentry","category-anticoagulation-2","category-prevention","tag-cardiovascular-disease","tag-elderly","tag-statins"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/38214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/577"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=38214"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/38214\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=38214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=38214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=38214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}